This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A Second View: Checking in with a prescriber of Apellis' Syfovre in treating Geographic Atrophy (GA)
Ticker(s): APLSWho's the expert?
Institution: Tulane & Private Practice
- Ophthalmologist and retina specialist in private practice in Louisiana; staff ophthalmologist at Tulane Medical Center & the Veterans Hospital in New Orleans.
- Manages 400 patients with Wet AMD.
- Collaborating researcher at the CLEVER Eye Institute and Louisiana Eye Research Institute (LERI); Extensive clinical experience in macular hole repair, retinal detachment repair and membrane removals.
Interview GoalUnderstanding if the use of Apellis' Syfovre has changed the landscape of Geographic Atrophy.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
